Home/Filings/4/0000899243-20-035444
4//SEC Filing

Turtle Cameron 4

Accession 0000899243-20-035444

CIK 0001743881other

Filed

Dec 28, 7:00 PM ET

Accepted

Dec 29, 9:14 PM ET

Size

18.6 KB

Accession

0000899243-20-035444

Insider Transaction Report

Form 4
Period: 2020-12-28
Turtle Cameron
See Remarks
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2020-12-287,500255,500 total
    Exercise: $17.00Exp: 2029-06-26Common Stock (7,500 underlying)
  • Exercise/Conversion

    Common Stock

    2020-12-28$0.34/sh+6,000$2,04026,068 total
  • Sale

    Common Stock

    2020-12-28$69.94/sh8,563$598,85512,568 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2020-12-286,00031,766 total
    Exercise: $0.34From: 2020-05-19Exp: 2029-07-14Common Stock (6,000 underlying)
  • Exercise/Conversion

    Common Stock

    2020-12-28$17.00/sh+7,500$127,50020,068 total
  • Exercise/Conversion

    Common Stock

    2020-12-28$0.16/sh+6,000$96032,068 total
  • Sale

    Common Stock

    2020-12-28$69.34/sh10,937$758,32921,131 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2020-12-286,00056,042 total
    Exercise: $0.16From: 2020-05-19Exp: 2029-05-23Common Stock (6,000 underlying)
Footnotes (4)
  • [F1]This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 29, 2020.
  • [F2]Represents the weighted average sale price of the shares sold from $68.73 to $69.725 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3.
  • [F3]Represents the weighted average sale price of the shares sold from $69.73 to $70.52 per share.
  • [F4]The shares subject to this option vest and become exercisable in 48 equal monthly installments after June 26, 2019, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Issuer

BridgeBio Pharma, Inc.

CIK 0001743881

Entity typeother

Related Parties

1
  • filerCIK 0001758363

Filing Metadata

Form type
4
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 9:14 PM ET
Size
18.6 KB